VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Cholecalciferol daily dose
Preclinical
Small molecule
U
University Hospital, Montpellier
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Hypercalciuria
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Hypercalciuria
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
Hypercalciuria
1 trial
Evaluation de l'Impact d'un Mode de supplémentation en Vitamine D (Dose séquentielle vs Dose Quotidienne) Sur l'Incidence de l'Hypercalciurie Chez Des Sujets Des départements du Gard et de l'Hérault agés de 2 à 18 Ans. Etude contrôlée randomisée en 2 Groupes parallèles
Completed
·
U
University Hospital, Montpellier
·
Preclinical
·
NCT02975492
·
280 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Cholecalciferol daily dose. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Cholecalciferol daily dose compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Cholecalciferol daily dose. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
University Hospital, Montpellier company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
U
University Hospital, Montpellier
Related News